(Q39520749)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Chien-chih Chiu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

J C Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

C K Tseng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

S F Wu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Y C Wu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

1 reference

20 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

Journal of Viral Hepatitis

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

e315-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of hepatitis C

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Unravelling hepatitis C virus replication from genome to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Hepatitis C Virus Stimulates the Expression of Cyclooxygenase-2 via Oxidative Stress: Role of Prostaglandin E2 in RNA Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study .

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

State of hepatitis C viral replication enhances activation of NF-kB- and AP-1-signaling induced by hepatitis B virus X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

San-Huang-Xie-Xin-Tang reduces lipopolysaccharides-induced hypotension and inflammatory mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

San-Huang-Xie-Xin-Tang attenuates inflammatory responses in lipopolysaccharide-exposed rat lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

San-Huang-Xie-Xin-Tang inhibits Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Potential ex vivo immunomodulatory effects of San-Huang-Xie-Xin-Tang and its component herbs on mice and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Two-year experience with "San-Huang-Hsieh-Hsin-Tang" in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Hemodynamic effects of "san-huang-hsieh-hsin-tang" in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Relationship Between San-Huang-Xie-Xin-Tang and its herbal components on the gene expression profiles in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Computational investigation of the anti-HIV activity of Chinese medicinal formula Three-Huang Powder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Anti-hepatitis B virus activity of wogonin in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Antiviral Chinese medicinal herbs against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Efficient initiation of HCV RNA replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Development of a cell-based assay for monitoring specific hepatitis C virus NS3/4A protease activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

A cell-based reporter assay for inhibitor screening of hepatitis C virus RNA-dependent RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Combinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Proanthocyanidin from Blueberry Leaves Suppresses Expression of Subgenomic Hepatitis C Virus RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Resistance to direct antiviral agents in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Hepatitis C virus RNA replication is regulated by Ras-Erk signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Anti-bovine viral diarrhoea virus and hepatitis C virus activity of the cyclooxygenase inhibitor SC-560.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Biological interactions between herpesviruses and cyclooxygenase enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

RSV-induced prostaglandin E2 production occurs via cPLA2 activation: role in viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Enterovirus 71 induces COX-2 expression via MAPKs, NF-kappaB, and AP-1 in SK-N-SH cells: Role of PGE(2) in viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

Structural biology of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01424.X

A study of Helicobacterium pylori and prevention and treatment of chronic atrophic gastritis.

21 January 2018

1 reference

12 December 2020

Effects of San-Huang-Xie-Xin-Tang on U46619-induced increase in pulmonary arterial blood pressure

1 reference

12 December 2020

San-Huang-Xie-Xin-Tang Protects against Activated Microglia- and 6-OHDA-Induced Toxicity in Neuronal SH-SY5Y Cells.

1 reference

12 December 2020

The role of gastric muscle relaxation in cytoprotection induced by san-huang-xie-xin-tang in rats

1 reference

12 December 2020

Metabolism and pharmacokinetics of san-huang-xie-xin-tang, a polyphenol-rich chinese medicine formula, in rats and ex-vivo antioxidant activity

1 reference

12 December 2020

Drug synergism: its detection and applications

1 reference

12 December 2020

Synergistic effect of a novel oxymatrine-baicalin combination against hepatitis B virus replication, alpha smooth muscle actin expression and type I collagen synthesis in vitro

1 reference

12 December 2020

The natural history of hepatitis C virus infection

1 reference

12 December 2020

Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication.

1 reference

12 December 2020

10.1111/J.1365-2893.2010.01424.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

1 reference